Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms - Wikidata - awgldk - TriplyDB

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

http://www.wikidata.org/entity/Q37682486

about

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations Hepatitis C virus and neurological damage Hepatitis C Virus, Insulin Resistance, and Steatosis Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus Extrahepatic manifestations of chronic hepatitis C virus infection Hepatitis C virus as a systemic disease: reaching beyond the liver Assessing cardiovascular risk in hepatitis C: An unmet need Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Management of Neurologic Manifestations in Patients with Liver Disease.The effect of Hepatitis C Virus infection on cardiovascular complications in end stage kidney disease patients on regular hemodialysis.Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions.The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking Maternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studies The effect of standard therapy on mean platelet volume in patients with chronic hepatitis C Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.New insights into HCV-related rheumatologic disorders: A review.Hepatitis C virus and cardiovascular: A review.Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis Neurologic manifestations of gastrointestinal and liver diseases.Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review.Hepatitis C and its impact on renal transplantation.Beclabuvir for the treatment of hepatitis C.Chronic hepatitis C virus infection, a new cardiovascular risk factor?Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.Effects of murine norovirus on atherosclerosis in ldlr(-/-) mice depends on the timing of infection.Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications.Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.Elevated Serum Homocysteine (Hcy) Levels May Contribute to the Pathogenesis of Cerebral Infarction.Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?

P2860

Q26745576-1C971EE1-3F7A-4B30-8661-35B21C7063F2 Q26748575-3E817EB8-7E40-4DDE-8C96-1047BFB67FAF Q26751755-67220614-237C-41F3-BD12-29491CD5C577 Q26752583-5DE36982-6FBA-4BD3-AC60-4EE25D5D89EE Q26765245-FA2D531F-70A3-4292-A1AB-7C28D1B9BD7B Q26767084-1BA7B2F5-1E00-4041-AE2B-DA60584F6936 Q26776387-B56224C7-ADEC-40FE-A506-40DBB0C504C6 Q26784258-B8FF9A11-8653-4FAC-9033-E272607C01D3 Q28079826-30659510-C8C9-4CBD-82B6-5DEABDE20EE0 Q28081216-A8735D63-4E9D-4172-AE85-CF8990D1AA17 Q28082212-2A096614-F8D8-4489-93E4-93F0B99C8106 Q30235846-E8EDD712-A4DB-4979-BC46-41F9D4527F09 Q31108752-F9CB5F4F-D927-4DE6-BBD9-C9C0FA7835FE Q33620417-0FA6C527-4842-4E72-91FB-7F650EF4A319 Q33803319-EFDBA215-758E-47BE-902B-35F4AC5F9C86 Q34128534-042DC439-8B30-49E9-8B18-A1A48860D0DB Q35678746-F503F73F-FDBD-4F17-8656-36459E86DF51 Q36077546-7B75005C-9ADE-4CE2-B23A-1B5808C017A3 Q36183998-95E1CC3E-9D69-4C7D-B3E0-DFB9FF673394 Q36723994-67FB5A93-39F7-4D22-AA0C-9E867BEBEFCB Q37226463-BBD8989D-A8A3-4587-839D-CE51D3F3926C Q37306570-1321B51B-83E7-4921-B6D8-68CF983C119D Q37513094-46B76210-F358-4DCA-BE02-A6FB915AF81E Q37610871-A322137E-2768-4380-B0A5-E1C54590BF96 Q37610905-507E9AA1-199D-412F-AA49-5751369C8C7E Q37672242-367FDEE7-E01D-4429-8C92-5514521C4285 Q38244670-2E5C037C-2616-4AAD-A3E4-5BB09E011E43 Q38332239-B8E56057-CA70-46E3-A1CE-6616C5808475 Q38341218-6CC8DAD5-485A-4694-9791-F58EF87AD45C Q38544196-24482E84-9385-41DC-BE13-9234CF07985B Q38695606-EAF1A576-9CE3-429A-82F6-DBFFAC551F36 Q38946641-0564ADA4-669E-403A-B9EB-F6C376435E16 Q39008634-E0FE91CB-A903-4076-9A24-265425BAFB7A Q39936190-7928BFCB-2C47-4625-8E63-94BDBC0AAC0E Q47551957-4D0C0531-CEC4-485B-BE9B-2FF00BEF4FE4 Q47560053-AAB8B832-BB6A-4513-9075-BAA16734B64B Q48328621-5F648211-CA51-471D-B5A5-B29DA6D9BE1A Q52359166-DB9835D2-9CBE-4D43-A388-B26BA10BEAF6 Q58699647-093B1B88-2652-4A44-BF91-2B88929DB21B

P2860

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

http://www.wikidata.org/entity/Q37682486

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

@en

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

@nl

type

label

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

@en

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

@nl

prefLabel

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

@en

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

@nl

P1433

Q37682486-D21DA802-26DD-4ACB-A767-ED7A0834DB2E

P1476

Q37682486-D4C46EC6-B3D6-464A-A0E4-5A7D82C46678

P2093

Q37682486-15F0FDE2-D862-41D7-896C-2639F6C9D182

Q37682486-2E9BADAC-39F1-46C2-816C-8FAB0573B960

Q37682486-6C3EE9EB-4001-4873-81A3-99EEA071ADD5

Q37682486-81DA5826-BDAF-447B-9781-4FB77FB6EC19

Q37682486-89CA0BE6-0D16-4ABD-8822-51956DBA1C98

P2860

Q37682486-0847E119-3868-4D59-BA3B-AD693E056C7E

Q37682486-0B08C933-C819-416C-B2EC-200B8F777617

Q37682486-1432CF5B-63A8-4587-8204-4D06587B1521

Q37682486-1D57A3E8-18A8-411D-B916-74F0E948D508

Q37682486-1DFC0D3F-A533-40D8-99C3-654622E86959

Q37682486-22EA8A96-04E0-4681-B4E3-E81CF40B9BA6

Q37682486-2F14452A-60C8-46B5-A3FE-255CBB55C65F

Q37682486-30A4DE88-656F-43A0-BE4F-15996F955FF1

Q37682486-37CEF7F4-E598-4C28-87B2-D7C951D4D1DF

Q37682486-437594B6-3D78-4BCB-96BF-51424BD55B84

P304

Q37682486-39C2DDAE-63F9-45C3-9059-1C0BCCFE81D3

P31

Q37682486-297CC629-6821-41E8-98FA-CC6FC41828A2

P356

Q37682486-FB9A55A3-65FF-4890-A49F-20BC4420CF9E

P407

Q37682486-43633B76-9AE4-4743-9618-C2282D7A5904

P433

Q37682486-AFB7DCBB-952D-41AA-935F-5AF9BB58C7E7

P478

Q37682486-6AF3F704-5AFD-42F3-8731-9AA83B77BDFF

P50

Q37682486-3473EBCA-5D94-443F-B887-1D2F97C17DED

Q37682486-388F2541-E094-4BE2-ACB1-299BB089F62C

Q37682486-5CCDF83A-2DE1-424B-BF47-41BE90B7B58D

Q37682486-E9D9C7F2-9B31-4E91-BC15-E3EA49C1C602

P577

Q37682486-242C8D7D-4A10-4452-87A5-372282D2CED4

P5875

Q37682486-289411AC-03B4-42BA-B741-62B5EE910598

P698

Q37682486-F5307205-1DF3-4089-987C-5CE1C44452FA

P921

Q37682486-D1BDE5D8-185C-4AFD-A117-E06B574A8F4B

P932

Q37682486-59C699A1-354F-49C8-A0BA-D522AF4398F9

P356

WJG.V20.I13.3410

P1433

World Journal of Gastroenterology

P1476

Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms

@en

P2093

Aldo Marrone

http://www.w3.org/2001/XMLSchema#string

Barbara Guerrera

http://www.w3.org/2001/XMLSchema#string

Luciano Restivo

http://www.w3.org/2001/XMLSchema#string

Luigi E Adinolfi

http://www.w3.org/2001/XMLSchema#string

Paola Loria

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

Association of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul Study

Hepatitis C virus infection

Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study.

Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors

Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study.

Does hepatitis C virus infection increase risk for stroke? A population-based cohort study.

Hepatitis C virus infection and the risk of coronary disease.

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.

P304

3410-3417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I13.3410

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Nascimbeni

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261410228

http://www.w3.org/2001/XMLSchema#string

P698

24707124

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3974508

http://www.w3.org/2001/XMLSchema#string